Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 6:50 pm Purchase |
2025-03-31 | 13G | Solid Biosciences Inc. SLDB |
Invus Public Equities, L.P. | 7,415,905 9.600% |
3,666,864 (+97.81%) |
Filing History |
| 2025-02-25 4:05 pm Purchase |
2025-02-18 | 13G | Solid Biosciences Inc. SLDB |
Commodore Capital LP | 5,825,000 7.600% |
5,825,000 (New Position) |
Filing History |
| 2025-02-21 6:04 pm Purchase |
2025-02-19 | 13D | Solid Biosciences Inc. SLDB |
BCLS SB Investco, LP | 6,179,042 7.800% |
3,877,087 (+168.43%) |
Filing History |
| 2025-02-21 4:15 pm Purchase |
2025-02-19 | 13D | Solid Biosciences Inc. SLDB |
RA Capital Management, L.P. | 7,989,820 9.900% |
3,631,342 (+83.32%) |
Filing History |
| 2025-02-21 4:15 pm Purchase |
2025-02-19 | 13D | Solid Biosciences Inc. SLDB |
PERCEPTIVE ADVISORS LLC | 11,934,679 15.600% |
5,000,001 (+72.10%) |
Filing History |
| 2025-02-14 08:30 am Sale |
2024-12-31 | 13G | Solid Biosciences Inc. SLDB |
Camber Capital Management LP | 0 0.000% |
-1,418,440 (Position Closed) |
Filing History |
| 2025-02-12 4:30 pm Purchase |
2024-12-31 | 13G | Solid Biosciences Inc. SLDB |
Invus Public Equities, L.P. | 3,749,041 9.400% |
1,000,000 (+36.38%) |
Filing History |
| 2024-11-14 7:59 pm Purchase |
2024-11-14 | 13D | Solid Biosciences Inc. SLDB |
PERCEPTIVE ADVISORS LLC | 6,934,678 17.300% |
6,934,678 (New Position) |
Filing History |
| 2024-11-14 12:02 pm Purchase |
2024-09-30 | 13G | Solid Biosciences Inc. SLDB |
Vestal Point Capital, LP | 2,800,000 7.300% |
2,800,000 (New Position) |
Filing History |
| 2024-11-14 08:56 am Sale |
2024-09-30 | 13G | Solid Biosciences Inc. SLDB |
Flynn James E | 0 0.000% |
-2,260,398 (Position Closed) |
Filing History |
| 2024-11-12 4:58 pm Purchase |
2024-09-30 | 13G | Solid Biosciences Inc. SLDB |
Invus Public Equities, L.P. | 2,749,041 7.100% |
240,898 (+9.60%) |
Filing History |
| 2024-11-12 09:30 am Purchase |
2024-09-30 | 13G | Solid Biosciences Inc. SLDB |
Adage Capital Management L.P. | 1,754,159 4.550% |
1,754,159 (New Position) |
Filing History |
| 2024-11-01 4:10 pm Sale |
2024-09-30 | 13G | Solid Biosciences Inc. SLDB |
MILLENNIUM MANAGEMENT LLC | 1,117,097 2.900% |
-896,840 (-44.53%) |
Filing History |
| 2024-08-02 6:37 pm Purchase |
2024-07-25 | 13G | Solid Biosciences Inc. SLDB |
Invus Public Equities, L.P. | 2,508,143 6.500% |
2,508,143 (New Position) |
Filing History |
| 2024-06-12 6:26 pm Purchase |
2024-06-11 | 13D | Solid Biosciences Inc. SLDB |
RA Capital Management, L.P. | 4,358,478 11.300% |
9,650 (+0.22%) |
Filing History |
| 2024-06-11 8:43 pm Unchanged |
2024-06-07 | 13D | Solid Biosciences Inc. SLDB |
BCLS SB Investco, LP | 2,301,955 6.000% |
0 (Unchanged) |
Filing History |
| 2024-06-05 4:12 pm Purchase |
2024-05-30 | 13G | Solid Biosciences Inc. SLDB |
MILLENNIUM MANAGEMENT LLC | 2,013,937 5.200% |
2,013,937 (New Position) |
Filing History |
| 2024-02-07 5:22 pm Purchase |
2024-01-08 | 13G | Solid Biosciences Inc. SLDB |
ADAGE CAPITAL PARTNERS GP LLC | 2,712,478 7.250% |
2,712,478 (New Position) |
Filing History |
| 2024-01-22 4:31 pm Purchase |
2024-01-11 | 13G | Solid Biosciences Inc. SLDB |
Artal Participations S.a r.l | 2,717,538 7.300% |
2,717,538 (New Position) |
Filing History |
| 2024-01-12 5:11 pm Purchase |
2024-01-11 | 13D | Solid Biosciences Inc. SLDB |
PERCEPTIVE ADVISORS LLC | 6,925,028 18.600% |
3,423,763 (+97.79%) |
Filing History |